Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 601

1.

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.

Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T.

J Intern Med. 1998 May;243(5):373-80.

2.

Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.

Simons LA, Nestel PJ, Clifton P, Janus ED, Simons J, Parfitt A.

Med J Aust. 1992 Nov 2;157(9):584-9.

PMID:
1406416
3.
5.
7.

Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.

Sasaki S, Nakagawa M, Nakata T, Azuma A, Sawada S, Takeda K, Asayama J; Lipid Intrvention Study in Kyoto..

Circ J. 2002 Jan;66(1):47-52.

9.

Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.

Stalenhoef AF, Lansberg PJ, Kroon AA, Kortmann B, De Haan AF, Stuyt PM, Kastelein JJ.

J Intern Med. 1993 Jul;234(1):77-82.

PMID:
8326293
10.

[Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].

Ditschuneit HH, Dreyer M, Dammann HG, Ditschuneit H.

Med Klin (Munich). 1991 Mar 15;86(3):142-8. German.

PMID:
1903497
11.

Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.

Maciejko JJ, Brazg R, Shah A, Patil S, Rubenfire M.

Arch Fam Med. 1994 Nov;3(11):955-60.

PMID:
7804477
12.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
13.

Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.

Sprecher DL, Abrams J, Allen JW, Keane WF, Chrysant SG, Ginsberg H, Fischer JJ, Johnson BF, Theroux P, Jokubaitis L.

Ann Intern Med. 1994 Apr 1;120(7):537-43.

PMID:
8093139
14.
15.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-Rubió P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
16.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group..

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
17.

Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.

Hagen E, Istad H, Ose L, Bodd E, Eriksen HM, Selvig V, Bard JM, Fruchart JC, Borge M, Wolf MC, et al.

Eur J Clin Pharmacol. 1994;46(5):445-9.

PMID:
7957541
18.

Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.

Raskin P, Ganda OP, Schwartz S, Willard D, Rosenstock J, Lodewick PA, Cressman MD, Phillipson B, Weiner B, McGovern ME, et al.

Am J Med. 1995 Oct;99(4):362-9.

PMID:
7573090
19.

Supplemental Content

Support Center